01663nas a2200385   4500000000100000008004100001260001300042653001000055653002700065653002800092653001100120653002300131653001100154653001000165653000900175653002300184653002100207653002400228653002600252653001700278653001700295100001900312700001600331700001200347700001300359700001900372700001500391700001400406700001600420245011400436300001100550490000700561520069500568022001401263       2011                            d  c2011 Nov10aAdult10aAnti-Retroviral Agents10aCross-Sectional Studies10aFemale10aHIV Seropositivity10aHumans10aKenya10aMale10aPatient Compliance10aPatient Dropouts10aPrimary Health Care10aRetrospective Studies10aTuberculosis10aUrban Health1 aTayler-Smith K1 aZachariah R1 aManzi M1 aKizito W1 aVandenbulcke A1 aSitienei J1 aChakaya J1 aHarries A D00aAntiretroviral treatment uptake and attrition among HIV-positive patients with tuberculosis in Kibera, Kenya.  a1380-30 v163 a<p>Using data of human immunodeficiency virus-positive patients with tuberculosis from three primary care clinics in Kibera slums, Nairobi, Kenya, we report on the proportion that started antiretroviral treatment (ART) and attrition (deaths, lost to follow-up and stopped treatment) before and while on ART. Of 427 ART eligible patients, enrolled between January 2004 and December 2008, 70% started ART, 19% were lost to attrition and 11% had not initiated ART. Of those who started ART, 14% were lost to attrition, making a cumulative pre-ART and ART attrition of 33%. ART uptake among patients with TB was relatively good, but programme attrition was high and needs urgent addressing.</p>  a1365-3156